Insider Selling: Phreesia, Inc. (NYSE:PHR) COO Sells 1,892 Shares of Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) COO Evan Roberts sold 1,892 shares of the company's stock in a transaction dated Thursday, July 17th. The stock was sold at an average price of $26.89, for a total value of $50,875.88. Following the sale, the chief operating officer owned 772,915 shares in the company, valued at approximately $20,783,684.35. This trade represents a 0.24% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Phreesia Price Performance

NYSE PHR traded up $1.03 during trading on Monday, reaching $26.51. 597,110 shares of the company traded hands, compared to its average volume of 456,444. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.95 and a current ratio of 1.95. The stock's 50 day moving average price is $26.50 and its two-hundred day moving average price is $26.41. The company has a market cap of $1.58 billion, a price-to-earnings ratio of -35.82 and a beta of 0.72. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $30.53.

Phreesia (NYSE:PHR - Get Free Report) last issued its earnings results on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.06. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The company had revenue of $115.94 million during the quarter, compared to analysts' expectations of $115.00 million. During the same quarter in the previous year, the company posted ($0.05) EPS. The business's revenue for the quarter was up 14.5% compared to the same quarter last year. As a group, analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current year.

Institutional Investors Weigh In On Phreesia

Hedge funds and other institutional investors have recently made changes to their positions in the business. Johnson Financial Group Inc. lifted its holdings in shares of Phreesia by 381.3% during the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock worth $28,000 after purchasing an additional 896 shares during the period. Quarry LP raised its holdings in shares of Phreesia by 210.9% during the fourth quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after purchasing an additional 1,923 shares during the period. KBC Group NV acquired a new position in shares of Phreesia during the first quarter valued at about $74,000. Farther Finance Advisors LLC raised its holdings in shares of Phreesia by 9,375.0% during the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company's stock valued at $86,000 after purchasing an additional 3,000 shares during the period. Finally, CWM LLC raised its holdings in shares of Phreesia by 994.9% during the first quarter. CWM LLC now owns 4,040 shares of the company's stock valued at $103,000 after purchasing an additional 3,671 shares during the period. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Citigroup reissued a "buy" rating on shares of Phreesia in a report on Wednesday, May 28th. KeyCorp upped their price target on Phreesia from $28.00 to $35.00 and gave the stock an "overweight" rating in a research note on Monday, July 14th. Wall Street Zen upgraded Phreesia from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. Canaccord Genuity Group lowered their target price on Phreesia from $35.00 to $34.00 and set a "buy" rating for the company in a research note on Thursday, May 29th. Finally, Truist Financial increased their price target on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, May 29th. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia presently has an average rating of "Buy" and an average price target of $32.27.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.